<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7359800\results\search\zoonosis\results.xml">
  <result pre="2002â€&quot;2003 through severe acute respiratory syndrome (SARS), and in 2011," exact="Middle East respiratory syndrome" post="(MERS) for the first time. The causative agents for"/>
  <result pre="immune system are positioned throughout the body [12]. Impacts of" exact="Covid-19" post="on the human body COVID-19 is an RNA virus"/>
  <result pre="hypertension, are at risk for severe disease and death from" exact="SARS-CoV-2 infection" post="[[21], [22], [23]]. Mechanism of immune systems in the"/>
  <result pre="China SARS-CoV None [58] South Korea MERS-CoV None [59] Guinea" exact="Ebola" post="Nausea, skin erythema, fever. No major adverse events. [60]"/>
  <result pre="Nausea, skin erythema, fever. No major adverse events. [60] China" exact="Influenza" post="A (H1N1) None [61] China Influenza A (H1N1) None"/>
  <result pre="adverse events. [60] China Influenza A (H1N1) None [61] China" exact="Influenza" post="A (H1N1) None [62] China Influenza A (H1N1) None"/>
  <result pre="(H1N1) None [61] China Influenza A (H1N1) None [62] China" exact="Influenza" post="A (H1N1) None [63] China Influenza A (H1N1) None"/>
  <result pre="(H1N1) None [62] China Influenza A (H1N1) None [63] China" exact="Influenza" post="A (H1N1) None [64] Because there is no definite"/>
  <result pre="the treatment of patients with COVID-19. For the treatment of" exact="Ebola" post="virus infection in 2017, Gilead Sciences synthesized and developed"/>
  <result pre="existence of antibodies against it may suggest the neutralization of" exact="SARS-CoV-2 infection." post="To assess that phenomenon, they performed a pseudovirus particle-based"/>
  <result pre="J Allergy Immunol2020 2Yan-RongGuoQing-DongCaoZhong-SiHongYuan-YangTanShou-DengChenHong-JunJinThe origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak â€&quot; an update on the statusMil Med"/>
  <result pre="novel coronavirus infected pneumoniaN Engl J Med192020 4GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med2020 5KwokK.O.LaiF.WeiW.I.WongS.Y.S.TangJ.W.T.Herd immunity â€&quot; estimating"/>
  <result pre="February 2020] 21ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet2020(January) 22HuangC.WangY.LiX.RenL.ZhaoJ.HuY.Clinical features of"/>
  <result pre="(7)2020102554 47BinZhangShuyiLiuTanTan.WenhuiHuangYuhaoDongLuyanChenTreatment with convalescent plasma for critically ill patients with" exact="SARS-CoV-2 infection" post="chest2020 48ShenC.WangZ.ZhaoF.YangY.LiJ.YuanJ.Treatment of 5 critically ill patients with Covid-19"/>
  <result pre="SARS-CoV-2 infection chest2020 48ShenC.WangZ.ZhaoF.YangY.LiJ.YuanJ.Treatment of 5 critically ill patients with" exact="Covid-19" post="with convalescent plasmaJAMA3231620201582158932219428 49DuanK.LiuB.LiC.ZhangH.YuT.QuJ.Effectiveness of convalescent plasma therapy in"/>
  <result pre="centre experienceAntivir Ther23201861762229923831 60van GriensvenJ.EdwardsT.de LamballerieX.SempleM.G.GallianP.BaizeS.Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med3742016334226735992 61HungI.F.ToK.K.LeeC.-K.-K.LeeC.-K.-L.ChanK.YanW.-W.-W.Convalescent plasma"/>
  <result pre="of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of" exact="Ebola" post="and emerging virusesJ Med Chem60520171648166128124907 66RynesR.Antimalarial drugs in the"/>
  <result pre="and zoonotic coro-navirusesSci Transl Med93962017eaal3653 82MulanguS.DoddL.E.DaveyR.T.Thsihani MbayaO.ProschanM.MukadiD.A.Randomized controlled trial of" exact="Ebola" post="virus disease therapeuticsN Engl J Med3812420192293230331774950 83GreinJ.OhmagariN.ShinD.DiazG.AspergesE.CastagnaA.Compassion-ate use of"/>
  <result pre="Covid-19N Engl J Med2020(March) 87WangZ.YangB.LiQ.WenL.ZhangR.Clinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, ChinaClin Infect Dis2020(March) 88DengL.LiC.ZengQ.LiuX.LiX.ZhangH.Arbidol combined with LPV/r"/>
  <result pre="a retrospective cohort studyJ Infect2020(March) 89SissokoD.LaouenanC.FolkessonE.MLebingÂ´A.B.BeavoguiA.H.BaizeS.Exper-imental treatment with favipiravir for" exact="Ebola" post="virus disease (the JIKI Trial): a historically controlled, single-arm"/>
 </snippets>
</snippetsTree>
